Streetbeat News

Price Targets

AMD

Raymond James analyst Srini Pajjuri has maintained an Outperform rating on Advanced Micro Devices (AMD) but reduced the price target from $195 to $180.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:24 pm

GOOG

Susquehanna analyst Shyam Patil has maintained a Positive rating on Alphabet Inc. (NASDAQ:GOOG) and increased the price target from $150 to $170, indicating a bullish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:22 pm

AMD

Susquehanna analyst Christopher Rolland has maintained a Positive rating on Advanced Micro Devices (AMD) but has reduced the price target from $210 to $200.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:12 pm

AX

Raymond James analyst David Feaster has maintained an Outperform rating on Axos Financial (NYSE:AX) and increased the price target from $45 to $62.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:12 pm

DHR

Raymond James analyst Andrew Cooper has maintained an Outperform rating on Danaher Corporation (NYSE:DHR) and increased the price target from $240 to $270.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:10 pm

GABC

Raymond James analyst David Long has maintained an Outperform rating on German American Bancorp (NASDAQ:GABC) and increased the price target from $38 to $39.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:05 pm

TTGT

TechTarget (NASDAQ:TTGT) received mixed ratings from 7 analysts, with 3 bullish and 4 somewhat bullish ratings. The average 12-month price target is $44.14, up 17.71% from the previous $37.50. Analysts from UBS, Keybanc, Raymond James, and Needham have adjusted their price targets and ratings, reflecting their views on the company's market performance. TechTarget's financial performance shows challenges with a revenue decline of -26.2%, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio of 2.06.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 1:00 pm

HCA

Raymond James analyst John Ransom has maintained an Outperform rating on HCA Healthcare (NYSE:HCA) and increased the price target from $300 to $330, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 12:57 pm

SBUX

Stephens & Co. analyst Joshua Long has reiterated an Equal-Weight rating on Starbucks (NASDAQ:SBUX) and maintained a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 12:53 pm

DLB

Rosenblatt analyst Steve Frankel has reiterated a Buy rating on Dolby Laboratories (NYSE:DLB) and maintained a $98 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 12:47 pm